QNTA QNTA

Quanta (CE) Stock Price

0.0003
0.00 (0.0%)
0.0003
Volume 629,482
Bid Price
Ask Price
News -
Day High 0.0003

Low
0.0002

52 Week Range

High
0.053

Day Low 0.0003
Company Name Stock Ticker Symbol Market Type
Quanta Inc (CE) QNTA OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0003 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0003 0.0003 0.0003 0.0003 0.0003
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4 629,482 $ 0.0003 $ 189 - 0.0002 - 0.053
Last Trade Time Type Quantity Stock Price Currency
15:40:25 7,500 $ 0.0003 USD

Period:

Draw Mode:

Quanta Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 144.48k 481.60M 114.92M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
299.53k $ - - - -

more financials information »

Quanta (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QNTA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00030.00030.00030.0003254,7500.000.0%
1 Month0.00040.00040.00030.0003031440,632-0.0001-25.0%
3 Months0.00330.00470.00020.00198714,236,969-0.003-90.91%
6 Months0.0090.0110.00020.00356783,643,758-0.0087-96.67%
1 Year0.04870.0530.00020.0120493,177,008-0.0484-99.38%
3 Years14.0015.200.00020.04891942,065,299-14.00-100.0%
5 Years2.0019.000.00020.04905641,924,228-2.00-99.99%

Quanta (CE) Description

Quanta Inc., an applied science company, focuses on enhancing energy levels in plant matter to increase performance within the human body. Its proprietary technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company specializes in potentiating rare, naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. Through its subsidiary, Medolife Rx, Inc., the company's lead clinical development program includes Escozine, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company's polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. Medolife Rx has also launched the Immunapen line of immune system enhancers, which meet the needs of people that want to stay healthy, while providing additional benefits such as reduction in anxiety or stress, as well as increased energy and focus.


Your Recent History
USOTC
QNTA
Quanta (CE..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now